44 results on '"Aversa F"'
Search Results
2. Safety and efficacy of inactivated varicella zoster virus vaccine in immunocompromised patients with malignancies: a two-arm, randomised, double-blind, phase 3 trial
3. Preference for subcutaneous or intravenous administration of rituximab among patients with untreated CD20+ diffuse large B-cell lymphoma or follicular lymphoma: results from a prospective, randomized, open-label, crossover study (PrefMab)
4. Differences among young adults, adults and elderly chronic myeloid leukemia patients
5. Hema e-Chart Registry of invasive fungal infections in haematological patients: improved outcome in recent years in mould infections
6. OC.01.3 ENDOSCOPIC PANCREATIC SPHINCTEROTOMY IN PATIENTS WITH IPMN-RELATED RECURRENT PANCREATITIS: A SINGLE CENTER EXPERIENCE
7. OC.10.7 GOOD AGREEMENT BETWEEN ‘GEMELLI USCP SCORE’ AND ROSEMONT SCORE FOR THE DIAGNOSIS AND FOLLOW-UP OF CHRONIC PANCREATITIS
8. Haploidentical stem cell transplantation in leukemia
9. P-102 The impact of a multidisciplinary approach in the management of pancreatic disease
10. P.05.32 THE ROLE OF MULTIDISCIPLINARY APPROACH IN ENDOSCOPIC SLEEVE GASTROPLASTY
11. P.01.35 ENDOSCOPIC TRANSORAL FUNDOPLICATION WITH MUSE FOR GASTROESOPHAGEAL REFLUX DISEASE: RESULTS OF A SINGLE CENTER STUDY
12. V.02.1 ENDOSCOPIC TREATMENT OF A DIVERTICULAR OESOPHAGEAL DUPLICATION
13. V.02.5 PERORAL ENDOSCOPIC MYOTOMY FOR ACHALASIA, OCCURRED AFTER SLEEVE GASTRECTOMY
14. V.02.2 ENDOSCOPIC TREATMENT OF INTRAMURAL FISTULA E MUCOSAL TEAR OCCURRED AFTER PERORAL ENDOSCOPIC MYOTOMY
15. P.03.16 PERORAL ENDOSCOPIC MYOTOMY FOR THE TREATMENT OF ESOPHAGEAL MOTILITY DISORDERS: BASELINE CHARACTERISTICS AND PROCEDURAL OUTCOMES IN YOUNG AND ELDERLY PATIENTS
16. P.03.17 PERORAL ENDOSCOPIC MYOTOMY FOR THE TREATMENT OF ACHALASIA IN CHILDREN: EXPERIENCE OF A SINGLE CENTER WITH LONG TERM FOLLOW-UP
17. 2O - Favorable clinical outcome and response to immunotherapy share a common PD-L1/PD-1 based NSCLC immune contexture
18. P.11.4: Mucosal Healing with a Second Anti-Tnf in Patients with Ulcerative Colitis After the Failure of the Previous Anti-Tnf Treatment
19. HCV-related mixed cryoglobulinemia: Data from PITER, a nationwide Italian HCV cohort study
20. Steatosis in patients with HCV chronic liver disease: Baseline results from patients enrolled in the PITER cohort study
21. P.16.5 SAFETY AND EFFECTIVENESS OF PLASMA EXCHANGE IN SEVERE LIVER FAILURE
22. P.17.4 DOWNSTAGING THERAPY IN PATIENTS WITH INTERMEDIATE STAGE HCC (BCLC B) AS BRIDGE FOR TRANSPLANTATION: THE HEPATOCATT EXPERIENCE
23. P.16.9 SHORT TREATMENT WITH RIFAXIMIN IMPROVES BLOOD CEREBRAL FLOW AT TRANSCRANIAL DOPPLER AND PSYCHOMETRIC TESTS IN CIRRHOTIC PATIENTS WITH MINIMAL HEPATIC ENCEPHALOPATHY
24. P.16.8 ROLE OF TRANSCRANIAL DOPPLER (TCD) IN THE EVALUATION OF CEREBRAL HEMODYNAMIC IN CIRRHOTIC PATIENTS: CORRELATION WITH SEVERITY OF THE DISEASE AND MINIMAL HEPATIC ENCEPHALOPATHY (MHE) DEVELOPMENT
25. OC.04.3 PATIENT-TARGETED AND MULTIDISCIPLINARY MANAGEMENT IMPROVES SURVIVAL IN PATIENTS WITH HCC: THE HEPATOCATT EXPERIENCE
26. P.18.2 LONG-TERM MAINTENANCE OF SVR IN DIFFICULT-TO-TREAT HCV GENOTYPES IN LIVER TRANSPLANT RECIPIENTS WITH HCV RECURRENCE
27. P.13.7 COMPARISON BETWEEN TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION (TACE) AND TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION COMBINED WITH PERCUTANEOUS RADIOFREQUENCY ABLATION (TACE-RFA) FOR TREATMENT OF INTERMEDIATE HEPATOCELLULAR CARCINOMA (HCC)
28. P.11.15 IMPACT OF PORTAL VEIN THROMBOSIS ON HEPATOCELLULAR CARCINOMA TREATMENT OUTCOME. THE HEPATOCAT GROUP EXPERIENCE
29. P.11.13 EPIDEMIOLOGY OF PORTAL AND DEEP VEIN THROMBOSIS IN HOSPITALIZED CIRRHOTIC PATIENTS: A SINGLE CENTER EXPERIENCE
30. P.06.25 THE PREVALENCE OF SMALL BACTERIAL OVERGROWTH AND GAS PRODUCTION IN PATIENTS WITH SPINA BIFIDA
31. P.06.5 DIABETES AND GASTROINTESTINAL DISORDERS: THE EFFECT OF INTESTINAL METHANE PRODUCTION ON GLYCEMIC CONTROL
32. P.08.13 REDUCED DOSE AND DURATION OF SORAFENIB TREATMENT ARE ASSOCIATED TO TUMOR PROGRESSION IN PATIENTS WITH HEPATOCELLULAR CARCINOMA
33. P.08.8 LACK OF RESPONSE AND TUMOR RECURRENCE AFTER MULTIMODAL REPEATED TREATMENT
34. P.07.9 THE PREVALENCE OF “H2 NON PRODUCER” IN IBS POPULATION
35. F-24 Short treatment with sorafenib is associated to tumor progression in patients with hepatocellular carcinoma
36. F-23 Lack of response and tumor recurrence after multimodal repeated treatment for hepatocellular carcinoma similarly affect HCC patients survival. A HEPATOCAT group experience
37. PO022 Autoimmune phenomena, myelodysplastic syndromes, cytogenetics: a case report
38. Response of refractory Hodgkin's disease to monoclonal anti-CD30 immunotoxin
39. A MULTI-GAMMA ATTENUATION TECHNIQUE FOR THE QUANTITATIVE CHARACTERIZATION OF ARCHAEOLOGICAL METAL ALLOYS
40. 58 O - Successful engraftment of t-cell-depleted HLA-incompatible transplants
41. 59 O - Thiotepa improves results of t-cell-depleted bone marrow tranplants for acute leukemia. a seven year experience
42. 11 T-cell depleted haploidentical “three loci” mismatched marrow transplants by addition of T-cell depleted peripheral blood progenitor cells
43. 194 Myelodysplastic syndrome or leukemia developing after MDS treated by allogeneic bone marrow transplantation: Outcome of 90 adult patients
44. HISTIOCYTIC MEDULLARY RETICULOSIS
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.